ALEMG — Laboratoires Euromedis SA Cashflow Statement
0.000.00%
Last trade - 00:00- €14.20m
- €3.84m
- €54.18m
- 66
- 69
- 50
- 69
Annual cashflow statement for Laboratoires Euromedis SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
C2018 December 31st | C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 17 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.92 | -3.64 | 22.9 | 2.31 | -5.94 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -0.365 | 0.044 | 0.193 | 1.24 | 0.009 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.126 | 1.3 | -15.5 | 15.7 | 3.89 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.31 | -0.983 | 13.5 | 19.2 | -1.05 |
| Capital Expenditures | -1.95 | -1.36 | -0.66 | -1.84 | -1.03 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.075 | 0.133 | 0.068 | 0.707 | -0.038 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.88 | -1.23 | -0.592 | -1.13 | -1.07 |
| Financing Cash Flow Items | — | 0.031 | 0.03 | 0.03 | 0.03 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.12 | 3.47 | 9.29 | -1.25 | -2.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.07 | 1.26 | 22.2 | 16.9 | -4.52 |